全部影片專區

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE-downregulation and relieves urticaria symptoms

Essential version- UB-612, a Multitope Universal Vaccine Eliciting a Balanced B and T Cell Immunity

一個理想的新冠疫苗應該具備哪些特性與優勢？ (下集)

一個理想的新冠疫苗應該具備哪些特性與優勢？ (上集)

全球首創精準設計之廣譜新冠疫苗UB-612，優異臨床數據獲國際權威期刊《臨床研究期刊》肯定